Related Experiment Videos
Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia
1Department of Haematology and Oncology, University of Hanover Medical School, Germany.
Medical Oncology (Northwood, London, England)
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.
Leukemia research·2004
Chronic myeloid leukemia and acromegaly in POEMS syndrome.
Leukemia research·2002
Cyclooxygenase-2 selective inhibitors in cancer prevention and therapy: inflammopharmacological basis and translational prospects.
Medical oncology (Northwood, London, England)·2026
OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization.
Medical oncology (Northwood, London, England)·2026
p-Coumaric acid inhibits hepatocellular carcinoma through promoting ROS accumulation.
Medical oncology (Northwood, London, England)·2026
IGF2BP3 enhances paclitaxel resistance in bladder urothelial carcinoma by recognizing m6A-modified CENPA mRNA.
Medical oncology (Northwood, London, England)·2026
Beyond KRASG12C: emerging therapeutic strategies, patent landscape, and clinical progress in targeting KRAS-mutant cancers.
Medical oncology (Northwood, London, England)·2026
From pumps to networks: ABC transporters in leukemia resistance and microenvironmental adaptation.
Medical oncology (Northwood, London, England)·2026
Anti-idiotypic antibodies as molecular mimics of conserved influenza hemagglutinin epitopes.
Protein science : a publication of the Protein Society·2026
Neutrophil Extracellular Traps Block Fibrinolysis in Ischemic Stroke.
Annals of neurology·2026